Discovery could lead to new type of cancer treatment

July 16, 2012 By Dan Even
Nir Keidor

(Phys.org) -- Israeli researchers have identified a new mechanism for inducing the programmed death of cells, a discovery that could be used to develop novel methods for treating cancer.

The began with the identification of a protein, mitochondrial carrier homolog 2, in human . Mitochondria are the cells’ “power plants,” converting nutrients into the chemical energy required for the cell’s ongoing operations.

The MTCH2 protein was discovered by Prof. Atan Gross of the Weizmann Institute’s Department of Biological Regulation, and first published in the medical literature in 2005. About two years ago it was discovered that in the cell, the protein acts as receptor for a different protein, known as BID, which plays a significant role in postponing cell death.

Subsequent research by a team headed by Gross and Prof. Assaf Friedler of the Hebrew University of Jerusalem’s Institute of Chemistry studied the interaction of these two proteins. Researchers found that while BID helps postpone cell death in the nucleus, it is essential for inducing apoptosis, or programmed cell death, in the mitochondria.

“This is an essential process that occurs in many mechanisms within the human body and involves many different types of proteins,” Gross said, explaining that it is part of the body’s defense mechanism against the spread of irregular cells. In practice, he explained, many cancerous cells are resistant to apoptosis.

According to the website of the Weizmann Institute, “If clinicians could regulate the production and activity of MTCH2, they would be able, for instance, to ‘turn on’ mitochondria apoptosis in cancerous cells and turn it ‘off’ in the brain cells of patients with Parkinson’s and Alzheimer’s diseases. Prof Gross’s team is now working to further elucidate how BID induces apoptosis, and the exact role of mitochondria in the cell’s ‘self-destruct’ decision.”

Molecular and biophysical studies of the binding interface between the two proteins led researchers to short protein strands called peptides, that induce cell death. In laboratory experiments these peptides caused the self-destruction of bone (osteosarcoma) cells. Gross said the effect of these peptides can now be tested on other types of cancer cells.

The latest findings were published in a recent issue of the Journal of Biological Chemistry, in an article entitled, “Molecular Basis of the Interaction between Proapoptotic Truncated BID (tBID) Protein and Mitochondrial Carrier Homologue (MTCH2) .”

The next stage of the research will be to determine whether the mechanism affects only and to assess its effect on healthy , with the aim of going on to studies using mice and then to developing the commercial potential of the discovery.

Explore further: Key step in the 'puncture' mechanism of cell death revealed

Related Stories

Key step in the 'puncture' mechanism of cell death revealed

May 12, 2008

A team of medical researchers led by Dr Ruth Kluck at Melbourne’s Walter and Eliza Hall Institute (WEHI) has discovered a key step in the mechanism by which cells destroy themselves. In this process, called “apoptosis”, ...

Immune cells kill foes by disrupting mitochondria 2 ways

May 15, 2008

When killer T cells of the immune system encounter virus-infected or cancer cells, they unload a lethal mix of toxic proteins that trigger the target cells to self-destruct. A new study shows T cells can initiate cellular ...

'Reaper' protein strikes at mitochondria to kill cells

October 20, 2010

Our cells live ever on the verge of suicide, requiring the close attention of a team of molecules to prevent the cells from pulling the trigger. This self-destructive tendency can be a very good thing, as when dangerous precancerous ...

Cell survival protein research reveals surprise structure

October 14, 2011

Researchers from the Walter and Eliza Hall Institute have found a structural surprise in a type of protein that encourages cell survival, raising interesting questions about how the proteins function to influence programmed ...

Recommended for you

Study reveals how nanochannels select potassium ions

August 25, 2015

(Phys.org)—One of the mysteries in biology is how cells can selectively diffuse potassium across a membrane. Biological systems rely on a delicate balance between these potassium and sodium ion concentrations in the surrounding ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.